36.46
-0.10
(-0.27%)
At close: January 10 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
16,095,000.00
16,095,000.00
17,803,000.00
20,976,000.00
18,566,000.00
Investing Cash Flow
-10,643,000.00
-10,643,000.00
-2,924,000.00
-6,552,000.00
-9,067,000.00
Financing Cash Flow
-4,239,000.00
-4,239,000.00
-16,275,000.00
-13,108,000.00
-9,666,000.00
End Cash Position
5,376,000.00
5,376,000.00
4,991,000.00
6,850,000.00
5,727,000.00
Capital Expenditure
-4,649,000.00
-4,649,000.00
-4,552,000.00
-4,549,000.00
-6,690,000.00
Issuance of Capital Stock
-1,144,000.00
-1,144,000.00
-1,257,000.00
-1,406,000.00
-2,126,000.00
Issuance of Debt
8,342,000.00
8,342,000.00
8,442,000.00
20,312,000.00
341,000.00
Repayment of Debt
-1,751,000.00
-1,751,000.00
-15,433,000.00
-2,448,000.00
--
Repurchase of Capital Stock
--
--
--
-18,991,000.00
--
Free Cash Flow
11,446,000.00
11,446,000.00
13,251,000.00
16,427,000.00
11,876,000.00
12/31/2020 - 8/20/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SNY Sanofi
48.73
-1.02%
NVS Novartis AG
99.08
-1.14%
GSK GSK plc
33.09
-1.96%
AZN AstraZeneca PLC
67.01
+0.65%
BAYRY Bayer Aktiengesellschaft
5.12
+0.99%
AMGN Amgen Inc.
262.23
-0.75%
BMY Bristol-Myers Squibb Company
55.83
-1.73%
GILD Gilead Sciences, Inc.
89.88
+0.83%
BIIB Biogen Inc.
148.82
-1.28%
MRK Merck & Co., Inc.
99.25
-0.60%